{"id":"W3091971999","doi":"10.1186/s12931-020-01503-z","title":"SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma","year":2020,"lang":"en","type":"article","venue":"Respiratory Research","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca; Amgen","keywords":"Medicine; Asthma; Exacerbation; Placebo; Adverse effect; Corticosteroid; Randomized controlled trial; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002292074,0.0014272,0.002289317,0.0004680773,0.000692189,0.001041586,0.001096685,0.002269655,0.02053809],"category_scores_gemma":[0.002212748,0.000544185,0.002354365,0.0004306086,0.000710388,0.00137607,0.0004817423,0.002693708,0.002321909],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005769405,"about_ca_system_score_gemma":0.001943696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007450187,"about_ca_topic_score_gemma":0.002341747,"domain_scores_codex":[0.9992094,0.0003452674,0.00005698657,0.000189035,0.0001121468,0.00008711319],"domain_scores_gemma":[0.9988834,0.0002811262,0.0002923612,0.00009328355,0.0001600161,0.0002898557],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9627996,0.007211093,0.0006269565,0.001950653,0.001113466,0.00004470487,0.00005403613,0.0002010533,0.004556926,0.0001454709,0.004119775,0.01717635],"study_design_scores_gemma":[0.9837505,0.0140399,0.0009233546,0.00004901311,0.0002512248,0.00002660191,0.000007889582,0.00009255608,0.000163383,0.00005162603,0.0006367778,0.000007223769],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8814167,0.01829502,0.004002667,0.003768997,0.002109805,0.05388718,0.02074427,0.001242134,0.01453331],"genre_scores_gemma":[0.9058559,0.008303951,0.0135424,0.006605893,0.001146564,0.04566002,0.009093435,0.0001856252,0.009606272],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02053809,"threshold_uncertainty_score":0.06870675,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09572569561784532,"score_gpt":0.3849696708320763,"score_spread":0.289243975214231,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}